{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T17:20:56Z","timestamp":1790097656887,"version":"4.0.1"},"reference-count":87,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Bloodwise program grant"},{"name":"The Medical College of Saint Bartholomew\u2019s Hospital Trust"},{"name":"Epizyme"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Hematology\/Oncology Clinics of North America"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.hoc.2020.02.010","type":"journal-article","created":{"date-parts":[[2020,5,5]],"date-time":"2020-05-05T08:07:41Z","timestamp":1588666061000},"page":"771-784","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["The Biological Basis of Histologic Transformation"],"prefix":"10.1016","volume":"34","author":[{"given":"Emil A.","family":"Kumar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Okosun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jude","family":"Fitzgibbon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.hoc.2020.02.010_bib1","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1200\/JCO.1997.15.4.1587","article-title":"Incidence, predictive factors, and outcome of lymphoma transformation in follicular lymphoma patients","volume":"15","author":"Bastion","year":"1997","journal-title":"J\u00a0Clin Oncol"},{"issue":"17","key":"10.1016\/j.hoc.2020.02.010_bib2","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1200\/JCO.2006.09.3260","article-title":"Risk and clinical implications of transformation of follicular lymphoma to diffuse large B-cell lymphoma","volume":"25","author":"Montoto","year":"2007","journal-title":"J\u00a0Clin Oncol"},{"issue":"32","key":"10.1016\/j.hoc.2020.02.010_bib3","doi-asserted-by":"crossref","first-page":"5165","DOI":"10.1200\/JCO.2008.16.0283","article-title":"Population-based analysis of incidence and outcome of transformed non-Hodgkin\u2019s lymphoma","volume":"26","author":"Al-Tourah","year":"2008","journal-title":"J\u00a0Clin Oncol"},{"issue":"7","key":"10.1016\/j.hoc.2020.02.010_bib4","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1182\/blood-2015-01-621375","article-title":"Outcomes of transformed follicular lymphoma in the modern era: a report from the National LymphoCare Study (NLCS)","volume":"126","author":"Wagner-Johnston","year":"2015","journal-title":"Blood"},{"issue":"26","key":"10.1016\/j.hoc.2020.02.010_bib5","doi-asserted-by":"crossref","first-page":"3272","DOI":"10.1200\/JCO.2012.48.3990","article-title":"Rates and outcomes of follicular lymphoma transformation in the immunochemotherapy era: a report from the university of Iowa\/mayo clinic specialized program of research excellence molecular epidemiology resource","volume":"31","author":"Link","year":"2013","journal-title":"J\u00a0Clin Oncol"},{"issue":"5","key":"10.1016\/j.hoc.2020.02.010_bib6","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1111\/bjh.14831","article-title":"Risk of, and survival following, histological transformation in follicular lymphoma in the rituximab era. A retrospective multicentre study by the Spanish GELTAMO group","volume":"178","author":"Alonso-\u00c1lvarez","year":"2017","journal-title":"Br J Haematol"},{"issue":"8","key":"10.1016\/j.hoc.2020.02.010_bib7","doi-asserted-by":"crossref","first-page":"e359","DOI":"10.1016\/S2352-3026(18)30090-5","article-title":"Rituximab and the risk of transformation of follicular lymphoma: a retrospective pooled analysis","volume":"5","author":"Federico","year":"2018","journal-title":"Lancet Haematol"},{"key":"10.1016\/j.hoc.2020.02.010_bib8","article-title":"Cause of death in follicular lymphoma in the first decade of the rituximab era: a pooled analysis of French and US cohorts","author":"Sarkozy","year":"2018","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.hoc.2020.02.010_bib9","series-title":"WHO classification of tumours of haematopoietic and lymhpoid tissues","author":"Swerdlow","year":"2008"},{"issue":"9","key":"10.1016\/j.hoc.2020.02.010_bib10","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1111\/j.1349-7006.2008.00873.x","article-title":"Diffuse large B-cell lymphoma after transformation from low-grade follicular lymphoma: morphological, immunohistochemical, and FISH analyses","volume":"99","author":"Maeshima","year":"2008","journal-title":"Cancer Sci"},{"issue":"4","key":"10.1016\/j.hoc.2020.02.010_bib11","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1111\/bjh.15816","article-title":"Outcome of transformed follicular lymphoma worsens according to the timing of transformation and to the number of previous therapies. A retrospective multicenter study on behalf of Fondazione Italiana Linfomi (FIL)","volume":"185","author":"Rusconi","year":"2019","journal-title":"Br J Haematol"},{"issue":"21","key":"10.1016\/j.hoc.2020.02.010_bib12","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1200\/JCO.19.00014","article-title":"Late relapses in patients with diffuse large B-cell lymphoma treated with immunochemotherapy","volume":"37","author":"Wang","year":"2019","journal-title":"J\u00a0Clin Oncol"},{"issue":"127","key":"10.1016\/j.hoc.2020.02.010_bib13","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","article-title":"The 2016 revision of the World Health Organization classification of lymphoid neoplasms","author":"Swerdlow","year":"2016","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.hoc.2020.02.010_bib14","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1097\/00000478-200004000-00006","article-title":"Blastic\/blastoid transformation of follicular lymphoma: immunohistologic and molecular analyses of five cases","volume":"24","author":"Natkunam","year":"2000","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.hoc.2020.02.010_bib15","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1002\/gcc.2870020211","article-title":"Clinical, morphologic, and cytogenetic characteristics of patients with lymphoid malignancies characterized by both t(14;18)(q32;q21) and t(8;14)(q24;q32) or t(8;22)(q24;q11)","volume":"2","author":"Thangavelu","year":"1990","journal-title":"Genes Chromosomes Cancer"},{"issue":"18","key":"10.1016\/j.hoc.2020.02.010_bib16","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1182\/blood-2015-06-649905","article-title":"Cell of origin of transformed follicular lymphoma","volume":"126","author":"Kridel","year":"2015","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.hoc.2020.02.010_bib17","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1200\/JCO.1999.17.5.1558","article-title":"Small noncleaved, non-Burkitt\u2019s (Burkitt-Like) lymphoma: cytogenetics predict outcome and reflect clinical presentation","volume":"17","author":"Macpherson","year":"1999","journal-title":"J\u00a0Clin Oncol"},{"issue":"10","key":"10.1016\/j.hoc.2020.02.010_bib18","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1093\/annonc\/mdl162","article-title":"The Follicular Lymphoma International Prognostic Index (FLIPI) and the histological subtype are the most important factors to predict histological transformation in follicular lymphoma","volume":"17","author":"Gin\u00e9","year":"2006","journal-title":"Ann Oncol"},{"issue":"4","key":"10.1016\/j.hoc.2020.02.010_bib19","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1200\/JCO.2006.06.1648","article-title":"Gene-expression and immunohistochemical study of specific T-cell subsets and accessory cell types in the transformation and prognosis of follicular lymphoma","volume":"25","author":"Glas","year":"2007","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.hoc.2020.02.010_bib20","doi-asserted-by":"crossref","first-page":"30","DOI":"10.4103\/2153-3539.120747","article-title":"Inter-reader variability in follicular lymphoma grading: conventional and digital reading","volume":"4","author":"Lozanski","year":"2013","journal-title":"J\u00a0Pathol Inform"},{"issue":"10","key":"10.1016\/j.hoc.2020.02.010_bib21","doi-asserted-by":"crossref","first-page":"3806","DOI":"10.1182\/blood.V99.10.3806","article-title":"Cytomorphologic, immunohistochemical, and cytogenetic profiles of follicular lymphoma: 2 types of follicular lymphoma grade 3","volume":"99","author":"Ott","year":"2002","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.hoc.2020.02.010_bib22","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1093\/annonc\/mdw185","article-title":"Clinical, pathological and genetic features of follicular lymphoma grade 3A: a joint analysis of the German low-grade and high-grade lymphoma study groups GLSG and DSHNHL","volume":"27","author":"Koch","year":"2016","journal-title":"Ann Oncol"},{"issue":"9","key":"10.1016\/j.hoc.2020.02.010_bib23","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.3324\/haematol.2011.042531","article-title":"Follicular lymphoma grade 3B is a distinct neoplasm according to cytogenetic and immunohistochemical profiles","volume":"96","author":"Horn","year":"2011","journal-title":"Haematologica"},{"issue":"7","key":"10.1016\/j.hoc.2020.02.010_bib24","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.3324\/haematol.2017.181024","article-title":"Gene expression profiling reveals a close relationship between follicular lymphoma grade 3A and 3B, but distinct profiles of follicular lymphoma grade 1 and 2","volume":"103","author":"Horn","year":"2018","journal-title":"Haematologica"},{"issue":"7","key":"10.1016\/j.hoc.2020.02.010_bib25","doi-asserted-by":"crossref","first-page":"3076","DOI":"10.1182\/blood-2006-09-045989","article-title":"CD10-MUM1+ follicular lymphoma lacks BCL2 gene translocation and shows characteristic biologic and clinical features","volume":"109","author":"Karube","year":"2007","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.hoc.2020.02.010_bib26","doi-asserted-by":"crossref","DOI":"10.1182\/blood.2019000258","article-title":"Early progression after BR is associated with high risk of transformation in advanced stage follicular lymphoma","volume":"134","author":"Freeman","year":"2019","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.hoc.2020.02.010_bib27","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.celrep.2013.12.027","article-title":"Genetics of follicular lymphoma transformation","volume":"6","author":"Pasqualucci","year":"2014","journal-title":"Cell Rep"},{"issue":"12","key":"10.1016\/j.hoc.2020.02.010_bib28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pmed.1002197","article-title":"Histological transformation and progression in follicular lymphoma: a clonal evolution study","volume":"13","author":"Kridel","year":"2016","journal-title":"PLoS Med"},{"key":"10.1016\/j.hoc.2020.02.010_bib29","first-page":"1405","article-title":"Aberrant somatic hypermutation in transformation of follicular lymphoma and chronic lymphocytic leukemia to diffuse large B-cell lymphoma","volume":"91","author":"Rossi","year":"2006","journal-title":"Haematologica"},{"issue":"4","key":"10.1016\/j.hoc.2020.02.010_bib30","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1182\/blood-2014-04-571786","article-title":"BCL2 mutations are associated with increased risk of transformation and shortened survival in follicular lymphoma","volume":"125","author":"Correia","year":"2015","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.hoc.2020.02.010_bib31","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1056\/NEJM198701083160204","article-title":"Multiple recurrent genomic defects in follicular lymphoma. A possible model for cancer","volume":"316","author":"Yunis","year":"1987","journal-title":"N\u00a0Engl J Med"},{"issue":"4","key":"10.1016\/j.hoc.2020.02.010_bib32","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1182\/blood.V84.4.1043.1043","article-title":"Prognostic value of chromosomal abnormalities in follicular lymphoma","volume":"84","author":"Tilly","year":"1994","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.hoc.2020.02.010_bib33","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1182\/blood-2010-03-272278","article-title":"Genomic alterations reveal potential for higher grade transformation in follicular lymphoma and confirm parallel evolution of tumor cell clones","volume":"116","author":"Eide","year":"2010","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.hoc.2020.02.010_bib34","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1182\/blood-2013-05-500595","article-title":"Genome-wide copy-number analyses reveal genomic abnormalities involved in transformation of follicular lymphoma","volume":"123","author":"Bouska","year":"2014","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.hoc.2020.02.010_bib35","doi-asserted-by":"crossref","first-page":"4677","DOI":"10.1182\/blood.V91.12.4677","article-title":"Homozygous deletions at chromosome 9p21 involving p16 and p15 are associated with histologic progression in follicle center lymphoma","volume":"91","author":"Elenitoba-Johnson","year":"1998","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.hoc.2020.02.010_bib36","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1182\/blood.V82.7.1994.1994","article-title":"p53 Mutation is associated with progression in follicular lymphomas","volume":"82","author":"Sander","year":"1993","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.hoc.2020.02.010_bib37","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1038\/ng.2856","article-title":"Integrated genomic analysis identifies recurrent mutations and evolution patterns driving the initiation and progression of follicular lymphoma","volume":"46","author":"Okosun","year":"2014","journal-title":"Nat Genet"},{"issue":"13","key":"10.1016\/j.hoc.2020.02.010_bib38","doi-asserted-by":"crossref","first-page":"8886","DOI":"10.1073\/pnas.132253599","article-title":"Transformation of follicular lymphoma to diffuse large-cell lymphoma: alternative patterns with increased or decreased expression of c-myc and its regulated genes","volume":"99","author":"Lossos","year":"2002","journal-title":"Proc Natl Acad Sci U\u00a0S\u00a0A"},{"issue":"15","key":"10.1016\/j.hoc.2020.02.010_bib39","doi-asserted-by":"crossref","first-page":"3158","DOI":"10.1182\/blood-2009-02-202465","article-title":"A\u00a0pluripotency signature predicts histologic transformation and influences survival in follicular lymphoma patients","volume":"114","author":"Gentles","year":"2009","journal-title":"Blood"},{"issue":"22","key":"10.1016\/j.hoc.2020.02.010_bib40","doi-asserted-by":"crossref","first-page":"2389","DOI":"10.1182\/blood-2018-06-855502","article-title":"miR-150 downregulation contributes to the high-grade transformation of follicular lymphoma by upregulating FOXP1 levels","volume":"132","author":"Musilova","year":"2018","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.hoc.2020.02.010_bib41","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1182\/blood-2017-08-799080","article-title":"FOXP1 expression is a prognostic biomarker in follicular lymphoma treated with rituximab and chemotherapy","volume":"131","author":"Mottok","year":"2018","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.hoc.2020.02.010_bib42","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1182\/blood-2002-08-2482","article-title":"BCL6 gene translocation in follicular lymphoma: a harbinger of eventual transformation to diffuse aggressive lymphoma","volume":"102","author":"Akasaka","year":"2003","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.hoc.2020.02.010_bib43","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/s41591-018-0016-8","article-title":"Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes","volume":"24","author":"Chapuy","year":"2018","journal-title":"Nat Med"},{"issue":"2","key":"10.1016\/j.hoc.2020.02.010_bib44","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.cell.2017.09.027","article-title":"Genetic and functional drivers of diffuse large B cell lymphoma","volume":"171","author":"Reddy","year":"2017","journal-title":"Cell"},{"issue":"15","key":"10.1016\/j.hoc.2020.02.010_bib45","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1056\/NEJMoa1801445","article-title":"Genetics and pathogenesis of diffuse large B-cell lymphoma","volume":"378","author":"Schmitz","year":"2018","journal-title":"N\u00a0Engl J Med"},{"issue":"Suppl 2","key":"10.1016\/j.hoc.2020.02.010_bib46","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1093\/annonc\/8.suppl_2.S119","article-title":"Somatic mutations of the translocated bcl-2 gene are associated with morphologic transformation of follicular lymphoma to diffuse large-cell lymphoma","volume":"8","author":"Matolcsy","year":"1997","journal-title":"Ann Oncol"},{"issue":"15","key":"10.1016\/j.hoc.2020.02.010_bib47","doi-asserted-by":"crossref","first-page":"3553","DOI":"10.1182\/blood-2008-08-174839","article-title":"Transformation of follicular lymphoma to diffuse large B-cell lymphoma may occur by divergent evolution from a common progenitor cell or by direct evolution from the follicular lymphoma clone","volume":"113","author":"Carlotti","year":"2009","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.hoc.2020.02.010_bib48","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1038\/sj.leu.2404696","article-title":"Genome-wide detection of recurring sites of uniparental disomy in follicular and transformed follicular lymphoma","volume":"21","author":"Fitzgibbon","year":"2007","journal-title":"Leukemia"},{"issue":"1","key":"10.1016\/j.hoc.2020.02.010_bib49","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1158\/2159-8290.CD-11-0208","article-title":"Molecular ontogeny of donor-derived follicular lymphomas occurring after hematopoietic cell transplantation","volume":"2","author":"Weigert","year":"2012","journal-title":"Cancer Discov"},{"issue":"9","key":"10.1016\/j.hoc.2020.02.010_bib50","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1182\/blood-2012-09-457283","article-title":"Hierarchy in somatic mutations arising during genomic evolution and progression of follicular lymphoma","volume":"121","author":"Green","year":"2013","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.hoc.2020.02.010_bib51","doi-asserted-by":"crossref","first-page":"E1116","DOI":"10.1073\/pnas.1501199112","article-title":"Mutations in early follicular lymphoma progenitors are associated with suppressed antigen presentation","volume":"112","author":"Green","year":"2015","journal-title":"Proc Natl Acad Sci U\u00a0S\u00a0A"},{"issue":"10","key":"10.1016\/j.hoc.2020.02.010_bib52","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1038\/nm.3940","article-title":"Disruption of KMT2D perturbs germinal center B cell development and promotes lymphomagenesis","volume":"21","author":"Zhang","year":"2015","journal-title":"Nat Med"},{"issue":"10","key":"10.1016\/j.hoc.2020.02.010_bib53","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1038\/nm.3943","article-title":"The histone lysine methyltransferase KMT2D sustains a gene expression program that represses B cell lymphoma development","volume":"21","author":"Ortega-Molina","year":"2015","journal-title":"Nat Med"},{"issue":"4","key":"10.1016\/j.hoc.2020.02.010_bib54","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1158\/2159-8290.CD-18-1090","article-title":"Molecular and genetic characterization of MHC deficiency identifies ezh2 as therapeutic target for enhancing immune recognition","volume":"9","author":"Ennishi","year":"2019","journal-title":"Cancer Discov"},{"key":"10.1016\/j.hoc.2020.02.010_bib55","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1038\/nchembio.1084","article-title":"A\u00a0selective inhibitor of EZH2 blocks H3K27 methylation and kills mutant lymphoma cells","volume":"8","author":"Knutson","year":"2012","journal-title":"Nat Chem Biol"},{"issue":"7427","key":"10.1016\/j.hoc.2020.02.010_bib56","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/nature11606","article-title":"EZH2 inhibition as a therapeutic strategy for lymphoma with EZH2-activating mutations","volume":"492","author":"McCabe","year":"2012","journal-title":"Nature"},{"issue":"19","key":"10.1016\/j.hoc.2020.02.010_bib57","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1182\/blood-2016-08-733469","article-title":"Crebbp loss cooperates with Bcl2 overexpression to promote lymphoma in mice","volume":"129","author":"Garc\u00eda-Ram\u00edrez","year":"2017","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.hoc.2020.02.010_bib58","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.tcb.2019.03.003","article-title":"Intratumoral heterogeneity: more than just mutations","volume":"29","author":"Hinohara","year":"2019","journal-title":"Trends Cell Biol"},{"issue":"6769","key":"10.1016\/j.hoc.2020.02.010_bib59","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/35000501","article-title":"Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling","volume":"403","author":"Alizadeh","year":"2000","journal-title":"Nature"},{"issue":"12","key":"10.1016\/j.hoc.2020.02.010_bib60","doi-asserted-by":"crossref","first-page":"7259","DOI":"10.1073\/pnas.1137463100","article-title":"Involvement of multiple signaling pathways in follicular lymphoma transformation: p38-mitogen-activated protein kinase as a target for therapy","volume":"100","author":"Elenitoba-Johnson","year":"2003","journal-title":"Proc Natl Acad Sci U\u00a0S\u00a0A"},{"issue":"21","key":"10.1016\/j.hoc.2020.02.010_bib61","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1056\/NEJMoa041869","article-title":"Prediction of survival in follicular lymphoma based on molecular features of tumor-infiltrating immune cells","volume":"351","author":"Dave","year":"2004","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1016\/j.hoc.2020.02.010_bib62","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1158\/1078-0432.CCR-09-2487","article-title":"A\u00a0unifying microenvironment model in follicular lymphoma: outcome is predicted by programmed death-1-positive, regulatory, cytotoxic, and helper T\u00a0cells and macrophages","volume":"16","author":"Wahlin","year":"2010","journal-title":"Clin Cancer Res"},{"issue":"1","key":"10.1016\/j.hoc.2020.02.010_bib63","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1111\/bjh.14201","article-title":"The tumour microenvironment influences survival and time to transformation in follicular lymphoma in the rituximab era","volume":"175","author":"Blaker","year":"2016","journal-title":"Br J Haematol"},{"issue":"11","key":"10.1016\/j.hoc.2020.02.010_bib64","doi-asserted-by":"crossref","first-page":"2862","DOI":"10.1158\/1078-0432.CCR-13-2367","article-title":"Pattern of CD14+ follicular dendritic cells and PD1+ T\u00a0cells independently predicts time to transformation in follicular lymphoma","volume":"20","author":"Smeltzer","year":"2014","journal-title":"Clin Cancer Res"},{"issue":"12","key":"10.1016\/j.hoc.2020.02.010_bib65","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.3324\/haematol.2009.021766","article-title":"Vascularization predicts overall survival and risk of transformation in follicular lymphoma","volume":"95","author":"Farinha","year":"2010","journal-title":"Haematologica"},{"issue":"5","key":"10.1016\/j.hoc.2020.02.010_bib66","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1078\/0344-0338-00421","article-title":"Disappearance of CD21-positive follicular dendritic cells preceding the transformation of follicular lymphoma: immunohistological study of the transformation using CD21, p53, Ki-67, and P-glycoprotein","volume":"199","author":"Shiozawa","year":"2003","journal-title":"Pathol Res Pract"},{"issue":"9","key":"10.1016\/j.hoc.2020.02.010_bib67","doi-asserted-by":"crossref","first-page":"2957","DOI":"10.1182\/blood-2006-04-018218","article-title":"High numbers of tumor-infiltrating FOXP3-positive regulatory T\u00a0cells are associated with improved overall survival in follicular lymphoma","volume":"108","author":"Carreras","year":"2006","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.hoc.2020.02.010_bib68","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1182\/blood-2009-07-235598","article-title":"The architectural pattern of FOXP3-positive T\u00a0cells in follicular lymphoma is an independent predictor of survival and histologic transformation","volume":"115","author":"Farinha","year":"2010","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.hoc.2020.02.010_bib69","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1200\/JCO.2008.18.0513","article-title":"High numbers of tumor-infiltrating programmed cell death 1-positive regulatory lymphocytes are associated with improved overall survival in follicular lymphoma","volume":"27","author":"Lopez-Guillermo","year":"2009","journal-title":"J\u00a0Clin Oncol"},{"issue":"1","key":"10.1016\/j.hoc.2020.02.010_bib70","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1155\/2010\/404069","article-title":"Diagnostic and prognostic utility of PD-1 in B cell lymphomas","volume":"29","author":"Muenst","year":"2010","journal-title":"Dis Markers"},{"issue":"4","key":"10.1016\/j.hoc.2020.02.010_bib71","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.humpath.2010.08.015","article-title":"Follicular programmed death 1-positive lymphocytes in the tumor microenvironment are an independent prognostic factor in follicular lymphoma","volume":"42","author":"Richendollar","year":"2011","journal-title":"Hum Pathol"},{"issue":"2","key":"10.1016\/j.hoc.2020.02.010_bib72","doi-asserted-by":"crossref","first-page":"e281","DOI":"10.1038\/bcj.2015.1","article-title":"PD-1 expression defines two distinct T-cell sub-populations in follicular lymphoma that differentially impact patient survival","volume":"5","author":"Yang","year":"2015","journal-title":"Blood Cancer J"},{"issue":"8","key":"10.1016\/j.hoc.2020.02.010_bib73","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1016\/j.celrep.2019.01.085","article-title":"Mass cytometry analysis reveals that specific intratumoral CD4\u00a0+ T\u00a0cell subsets correlate with patient survival in follicular lymphoma","volume":"26","author":"Yang","year":"2019","journal-title":"Cell Rep"},{"issue":"9","key":"10.1016\/j.hoc.2020.02.010_bib74","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1038\/s41590-018-0181-4","article-title":"Human germinal center transcriptional programs are de-synchronized in B cell lymphoma","volume":"19","author":"Milpied","year":"2018","journal-title":"Nat Immunol"},{"issue":"4","key":"10.1016\/j.hoc.2020.02.010_bib75","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/nmeth.2869","article-title":"Highly multiplexed imaging of tumor tissues with subcellular resolution by mass cytometry","volume":"11","author":"Giesen","year":"2014","journal-title":"Nat Methods"},{"issue":"4","key":"10.1016\/j.hoc.2020.02.010_bib76","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1016\/j.cell.2018.07.010","article-title":"Deep profiling of mouse splenic architecture with CODEX multiplexed imaging","volume":"174","author":"Goltsev","year":"2018","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.hoc.2020.02.010_bib77","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1182\/blood-2003-12-4434","article-title":"FLIPI: follicular lymphoma international prognostic index","volume":"104","author":"Solal-C\u00e9ligny","year":"2004","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.hoc.2020.02.010_bib78","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/S1470-2045(15)00169-2","article-title":"Integration of gene mutations in risk prognostication for patients receiving first-line immunochemotherapy for follicular lymphoma: a retrospective analysis of a prospective clinical trial and validation in a population-based registry","volume":"16","author":"Pastore","year":"2015","journal-title":"Lancet Oncol"},{"issue":"4","key":"10.1016\/j.hoc.2020.02.010_bib79","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/S1470-2045(18)30102-5","article-title":"A\u00a0gene-expression profiling score for prediction of outcome in patients with follicular lymphoma: a retrospective training and validation analysis in three international cohorts","volume":"19","author":"Huet","year":"2018","journal-title":"Lancet Oncol"},{"issue":"5","key":"10.1016\/j.hoc.2020.02.010_bib80","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1038\/s41375-018-0043-y","article-title":"Genomic profiling reveals spatial intra-tumor heterogeneity in follicular lymphoma","volume":"32","author":"Araf","year":"2018","journal-title":"Leukemia"},{"issue":"364","key":"10.1016\/j.hoc.2020.02.010_bib81","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1126\/scitranslmed.aai8545","article-title":"Distinct biological subtypes and patterns of genome evolution in lymphoma revealed by circulating tumor DNA","volume":"8","author":"Scherer","year":"2016","journal-title":"Sci Transl Med"},{"issue":"7","key":"10.1016\/j.hoc.2020.02.010_bib82","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1182\/blood-2013-07-512392","article-title":"Whole-genome integrative analysis reveals expression signatures predicting transformation in follicular lymphoma","volume":"123","author":"Brodtkorb","year":"2014","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.hoc.2020.02.010_bib83","doi-asserted-by":"crossref","first-page":"e460","DOI":"10.3324\/haematol.2018.209080","article-title":"A\u00a0clinico-molecular predictor identifies follicular lymphoma patients at risk of early transformation after first-line immunotherapy","volume":"104","author":"Steen","year":"2019","journal-title":"Haematologica"},{"issue":"30","key":"10.1016\/j.hoc.2020.02.010_bib84","doi-asserted-by":"crossref","first-page":"3618","DOI":"10.1200\/JCO.2016.66.9440","article-title":"Baseline metabolic tumor volume predicts outcome in high-tumor-burden follicular lymphoma: a pooled analysis of three multicenter studies","volume":"34","author":"Meignan","year":"2016","journal-title":"J\u00a0Clin Oncol"},{"issue":"1","key":"10.1016\/j.hoc.2020.02.010_bib85","doi-asserted-by":"crossref","first-page":"e17","DOI":"10.1016\/S2352-3026(14)70008-0","article-title":"Prognostic value of PET-CT after first-line therapy in patients with follicular lymphoma: a pooled analysis of central scan review in three multicentre studies","volume":"1","author":"Trotman","year":"2014","journal-title":"Lancet Haematol"},{"issue":"18","key":"10.1016\/j.hoc.2020.02.010_bib86","first-page":"1","article-title":"Prognostic value of end-of-induction PET response after first-line immunochemotherapy for follicular lymphoma (GALLIUM): secondary analysis of a randomised, phase 3 trial","volume":"2045","author":"Trotman","year":"2018","journal-title":"Lancet Oncol"},{"issue":"Supplement 1","key":"10.1016\/j.hoc.2020.02.010_bib87","doi-asserted-by":"crossref","first-page":"4160","DOI":"10.1182\/blood-2018-99-116686","article-title":"Baseline Suvmax did not predict histological transformation from follicular lymphoma to aggressive lymphoma in the phase III GALLIUM study","volume":"132","author":"Mir","year":"2018","journal-title":"Blood"}],"container-title":["Hematology\/Oncology Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889858820300356?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889858820300356?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T12:14:58Z","timestamp":1760184898000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889858820300356"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":87,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["S0889858820300356"],"URL":"https:\/\/doi.org\/10.1016\/j.hoc.2020.02.010","relation":{},"ISSN":["0889-8588"],"issn-type":[{"value":"0889-8588","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Biological Basis of Histologic Transformation","name":"articletitle","label":"Article Title"},{"value":"Hematology\/Oncology Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hoc.2020.02.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}